This program will provide you with a sense of confidence in medical practice, which will help you grow personally and professionally”

Clinical Dermatology has been gaining prominence as the pathophysiological mechanisms of the pathological processes affecting the skin and its annexes have become better understood. As a result, the means and ways of treating the diseases that manifest themselves in the skin have become more widely known. In fact, in recent times it has become a recurrent discipline in different sectors of care, being a common reason for consultation, both at primary and specialized care level. 

This scenario brings with it the challenge of maintaining a level of care that meets the new needs of the patient. For this reason, it is essential that the professionals who provide care to patients with dermatological pathology are properly qualified and have up-to-date knowledge in order to implement quality medicine. 

At the diagnostic level, the advances that are being made in the knowledge of the etiology of each of the diseases, emerging pathologies, new imaging and laboratory techniques and diagnostic algorithms that are in continuous renewal, leads us to the need to keep our knowledge of pediatric dermatology and other related specialties (pediatrics, genetics, radiology, etc.) that experience constant innovation. At the therapeutic level, the appearance of new drugs and techniques for already known pathologies and the need for new strategies for the integral approach to the patient make it more than necessary to know all the arsenal of resources that we could, if necessary, use to attend to our patients with the maximum guarantee. The program is designed to provide an online specialization equivalent to 3,000 hours, and all theoretical and practical knowledge is presented through high-quality multimedia content, analysis of clinical cases prepared by experts, master classes and video techniques that allow the exchange of knowledge and experience, maintain and update the educational level of its members, create protocols for action and disseminate the most important developments in the specialty. With online education, students can organize their own learning process, adapting it to their schedules, in addition to being able to access the contents from any computer or mobile device. 

This comprehensive program is designed for medical specialists interested in learning about the latest advances in the field of clinical dermatology and pediatric dermatology. In addition, this specialization program may be of interest to physicians from other specialties who wish to update their knowledge in a convenient way, without having to attend frequent scientific meetings or take multiple short specialization programs for each area of interest. 

Join the vanguard in general and pediatric dermatology with a high-intensity and high-quality specialization, without having to give up your obligations”

This Advanced master’s degree in Clinical Dermatology contains the most complete and up-to-date scientific program on the market. The most important features include:  

• This Advanced Master’s Degree in Clinical Dermatology contains the most complete and up-to-date scientific program on the market. The most important features include: 
• More than 100 clinical cases presented by experts in the different specialities 
• The graphic, schematic, and practical contents with which they are created, provide scientific and practical information on the disciplines that are essential for professional practice
• Diagnostic and therapeutic innovations on the most frequent skin diseases
• Presentation of practical workshops on procedures, diagnosis, and treatment techniques
• Contains real images in high resolution and practical exercises where the self-evaluation process can be carried out to improve learning
• Algorithm-based interactive learning system for decision making on clinical situations posed with a special emphasis on evidence-based medicine and research methodologies in dermatology
• All of this will be complemented by theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Content that is accessible from any fixed or portable device with an Internet connection

This Advanced master’s degree is the best investment you can make when selecting a refresher program, for two reasons: in addition to updating your knowledge in Clinical Dermatology, you will obtain a qualification from TECH Global University"

Forming part of the teaching staff is a group of professionals from the field of dermatology, who bring to this course their work experience, as well as a group of renowned specialists, recognized by esteemed scientific communities. 

The multimedia content developed with the latest educational technology will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide an immersive program to learn in real situations. 

This program is designed around Problem-Based Learning, whereby the physician must try to solve the different professional practice situations that arise during the course. For this purpose, the physician will be assisted by an innovative interactive video system created by renowned and experienced experts in the field of Clinical Dermatology with extensive teaching experience.  

Increase your decision-making confidence by updating your knowledge through this Advanced master’s degree of a program created to train the best"

Take the opportunity to learn about the latest advances in Clinical Dermatology and improve the care of your patients with a high-level of competent assistance"

The structure of the contents has been designed by a team of professionals from leading hospitals and universities, aware of the current relevance of specialization in order to be able to treat the patient with dermatological pathology and committed to quality teaching with new educational technologies. 

This Advanced master’s degree in Clinical Dermatology is an incomparable opportunity to obtain, in a single program, all the knowledge required in dermatology and pediatric dermatology"

Module 1. General Aspects

1.1. Structure and Function of the Skin 
1.2. Primary Skin Lesions 
1.3. Secondary Skin Lesions 
1.4. Diagnostic Techniques 
1.5. Dermatopathology  
1.6. The Importance of Dermatologic Semiology in the Diagnosis of Skin Disease
1.7. The Skin and the Endocrine System  
1.8. Skin Microbiology  
1.9. Nutrition and Skin 
1.10. Principles of Pharmacological Therapeutics in Dermatology
1.11. Corticosteroid Therapy in Dermatology  
1.12. Ultrasonography of the Skin and Appendages 

Module 2. Hereditary Diseases

2.1. Keratinization Disorders: Ichthyosis 
2.2. Keratinization Disorders: Familial Benign Pemphigus 
2.3. Keratinization Disorders: Darier's Disease 
2.4. Neurocutaneous Diseases: Neurofibromatosis 
2.5. Neurocutaneous Diseases: Tuberous Sclerosis 
2.6. Neurocutaneous Diseases: Sturge-Weber Syndrome 
2.7. Epidermolysis Bullosa 

Module 3. Inflammatory Diseases

3.1. Papulosquamous Dermatoses: Psoriasis 
3.2. Papulosquamous Dermatoses: Pityriasis Rubra Pilaris 
3.3. Papulosquamous Dermatoses: Pityriasis Rosea  
3.4. Papulosquamous Dermatoses: Acute Lichenoid Pityriasis and Varioliform Pityriasis 
3.5. Atopic Dermatitis 
3.6. Seborrheic Dermatitis 
3.7. Contact Dermatitis 
3.8. Blistering Diseases: Pemphigus 
3.9. Blistering Diseases: Pemphigoid 
3.10. Blistering Diseases: Dermatitis Herpetiformis 
3.11. Blistering Diseases: Linear IgA Dermatosis 
3.12. Pustular Rashes: Pemphigus IgA 
3.13. Neonatal Pustular Eruption 
3.14. Panniculitis 
3.15. Pustular Eruption Caused by Drugs
3.16. Pigmentation Disorders 
3.17. Vasculitis 
3.18. Toxicodermia 
3.19. Deposition Diseases 
3.20. Granulomatous Diseases 
3.21. Urticaria and Angioedema 

Module 4. Pilosebaceous Junction Pathology

4.1. Pilosebaceous Junction Structure  
4.2. Acne 
4.3. Rosacea 
4.4. Hidradenitis Suppurativa 
4.5. Alopecia 
4.6. Aesthetic Medicine in Skin Care and Pilosebaceous Junction Diseases 

Module 5. Connective Tissue and Autoimmune Diseases

5.1. Skin and Connective Tissue  
5.2. Rheumatoid Arthritis  
5.3. Systemic Lupus Erythematosus 
5.4. Scleroderma 
5.5. Dermatomyositis
5.6. Sjögren's Syndrome  
5.7. Ehlers - Danlos Syndrome 

Module 6. Infectious Diseases

6.1. Exanthematous Viral Skin Infections  
6.2. Non-Exanthematous Viral Skin Infections  
6.3. Cutaneous Manifestations of COVID-19  
6.4. Bacterial Skin Infections 
6.5. Mycotic Skin Infections: Dermatophytosis 
6.6. Leprosy 
6.7. Cutaneous Tuberculosis 
6.8. Endemic Treponematosis  
6.9. Sexually Transmitted Diseases 
6.10. Parasitic 

Module 7. Oncologic Dermatology

7.1. Benign Melanocytic Tumors 
7.2. Benign Fibrohistiocytic Tumors 
7.3. Malignant Tumors Merkel's Carcinoma 
7.4. Malignant Fibrohistiocytic Tumors 
7.5. Actinic Keratosis 
7.6. Non-Melanoma Skin Cancer 
7.7. Cutaneous Melanoma 
7.8. Cutaneous Sarcoma 
7.9. Cutaneous Paraneoplastic Syndrome 
7.10. Cutaneous Lymphomas 

Module 8. Dermatology in Special Population Groups

8.1. Neonatal Dermatology 
8.2. Pediatric Dermatology 
8.3. Adolescent Dermatology  
8.4. Geriatric Dermatology 
8.5. Pregnancy Dermatoses 
8.6. Dermatology of Black Skin 
8.7. Dermatology in Immunocompromised Patients 

Module 9. Cutaneous Manifestations of Internal Diseases

9.1. Cutaneous Manifestations of Endocrinology Diseases 
9.2. Cutaneous Manifestations of Renal Diseases 
9.3. HIV/AIDS 
9.4. Cutaneous Manifestations of Nutritional Disorders 
9.5. Cutaneous Manifestations of Digestive Diseases 
9.6. Cutaneous Manifestations of Cardiac Diseases 
9.7. Cutaneous Signs of Internal Malignancy 

Module 10. Other Areas of Interest in Dermatology

10.1. Nail Pathology 
10.2. Dermatological Emergencies
10.3. Oral Mucosal Pathology 
10.4. Photodermatology 
10.5. Vascular Malformations and Hemangiomas 
10.6. Urticaria and Angioedema 
10.7. Magistral Formulas 
10.8. Change to Skin Pigmentation Disorders  
10.9. Pressure Ulcers  
10.10. Genomics and Skin Care 

Module 11. Review of Congenital and Neonatal Skin Pathology

11.1. Physiological Skin Changes in Newborns

11.1.1. Neonatal Skin
11.1.2. Physiological Cutaneous Vascular Changes
11.1.3. Physiological Pigmentary Changes
11.1.4. Lanugo and Physiological Changes of the Hair

11.2. Benign and Transient Skin and Mucous Membranes Lesions

11.2.1. Milia
11.2.2. Bohn's Nodules and Epstein's Pearls
11.2.3. Congenital Epulis and Neonatal Teeth
11.2.4. Suction Calluses
11.2.5. Sebaceous Hyperplasia
11.2.6. Erythema Toxicum Neonatorum
11.2.7. Neonatal Acne
11.2.8. Minipuberty of Infancy
11.2.9. Eosinophilic Pustular Folliculitis
11.2.11. Melanosis Pustular Neonatal Transitoria
11.2.12. Suction Blisters
11.2.13. Seborrheic Dermatitis 

11.3. Developmental Abnormalities in Newborns

11.3.1. Facial Abnormalities
11.3.2. Cervical Abnormalities
11.3.3. Thoracic-Abdominal Disorders
11.3.4. Cutaneous Indicators of Dysraphism
11.3.5. What to Do When a Newborn Has Developmental Abnormalities?

11.4. Congenital Neonatal Infections

11.4.1. Bacterial Infections
11.4.2. Viral Infections
11.4.3. Fungal Infections

11.5. Erosive and Blistering Dermatoses

11.5.1. Erosive Dermatoses and Differential Diagnosis
11.5.2. Blistering Dermatoses and Differential Diagnosis

11.6. Neonatal Pathology Associated with Invasive Procedures during Gestation or Childbirth

11.6.1. Cutaneous Manifestations of Invasive Processes During pregnancy
11.6.2. Cutaneous Manifestations due to Trauma during Childbirth
11.6.3. Subcutaneous Fat Necrosis and Scleredema of the Newborn

Module 12. Eczematous and Papular Desquamative Dermatoses

12.1. Pathophysiology and Clinical Manifestations of Atopic Dermatitis (AD)

12.1.1. Epidemiology of AD
12.1.2. Atopic Dermatitis
12.1.3. AD Pathophysiology
12.1.4. Clinical Manifestations of AD in Different Periods of Childhood and Adolescence
12.1.5. Complications in the Progression of AD

12.2. Update on the Management and Treatment of Atopic Dermatitis

12.2.1. Diagnostic Tests to be Ordered
12.2.2. Indications for Systemic Allergy Studies
12.2.3. DA Treatment
12.2.4. Management of Patients with Moderate-Severe AD

12.3. Seborrheic Dermatitis

12.3.1. Epidemiology
12.3.2. Clinical Manifestations of Seborrheic Dermatitis in Childhood and Adolescence
12.3.3. Management of Seborrheic Dermatitis

12.4. Irritant and Allergic Contact Dermatitis

12.4.1. Irritant Contact Dermatitis in Infants
12.4.2. Allergic Contact Dermatitis in Childhood

12.5. Pathophysiology and Clinical Manifestations of Psoriasis

12.5.1. Epidemiology of Psoriasis
12.5.2. Pathophysiology of Psoriasis
12.5.3. Clinical Manifestations of Psoriasis in Different Periods of Childhood and Adolescence
12.5.4. Psoriatic Arthropathy

12.6. Management and Treatment of Infantile-Juvenile Psoriasis

12.6.1. Tests to Order
12.6.2. Step Treatment in Psoriasis
12.6.3. Management of Patients with Moderate-Severe Psoriasis

12.7. Pityriasis Rubra Pilaris and Lichen

12.7.1. Pityriasis Rubra
12.7.2. Lichen Planus
12.7.3. Lichen Aureus
12.7.4. Lichen Nitidus

12.8. Pityriasis Lichenoides and Lymphomatoid Papulosis

12.8.1. Pityriasis Lichenoides
12.8.2. Lymphomatoid Papulosis

Module 13. Update on Vascular Pathology

13.1. Child Hemangioma

13.1.1. Epidemiology and Pathophysiology
13.1.2. Progression
13.1.3. Clinical Presentation
13.1.4. Complications

13.2. Syndromes Associated to Child Hemangioma

13.2.1. PHACE
13.2.2. SACRAL/PELVIS

13.3. Update on the Use of Beta-Blockers in the Treatment of Child Hemangioma
13.4. Congenital Hemangiomas

13.4.1. RICH
13.4.2. NICH

13.5. Other Benign Vascular Tumors

13.5.1. Pyogenic Granuloma
13.5.2. Glomangioma
13.5.3. Verrucous Hemangioma
13.5.4. Spindle Cell Hemangioma
13.5.5. Eruptive Pseudoangiomatosis

13.6. Tumors of Intermediate Malignancy

13.6.1. Tufted Hemangioma
13.6.2. Kaposiform Hemangioendothelioma
13.6.3. Dabska Tumor
13.6.4. Multifocal Lymphangioendotheliomatosis with Thrombocytopenia
13.6.5. Retiform Hemangioendothelioma

13.7. Arteriovenous Malformations

13.7.1. Kaposi's Sarcoma
13.7.2. Cutaneous Angiosarcoma

13.8. Vascular Malformations Associated with Syndromes I
13.9. Vascular Malformations Associated with Syndromes II 
13.10. Polyarteritis Nodosa, Kawasaki Disease and Takayasu's Arteritis
13.11. Update on the Treatment and Multidisciplinary Management of Pediatric Patients with Vascular Malformations

13.11.1. Imaging Tests
13.11.2. Treatment of Vascular Anomalies Excluding Child Hemangioma
13.11.3. Vascular Anomalies Committees

13.12. Cutaneous Leukocytoclastic Vasculitis, Scholein-Henoch Purpura and Acute Hemorrhagic Edema of Infancy and Urticaria-Vasculitis
13.13. Approach to Pediatric Patients with Vasculitis
13.14. Malignant Tumors
13.15. Wegener's Granulomatosis, Churg-Strauss Syndrome, Microscopic Polyangiitis and Cryoglobulinemia
13.16. Capillary, Lymphatic, and Simple Venous Malformations
13.17. Inflammatory and Non-Inflammatory Purpuras

Module 14. Pathology of Skin Appendages

14.1. Alopecia Areata
14.2. Hypertrichosis and Hirsutism
14.3. Non-Scarring Alopecia with Structural Alteration of the Hair
14.4. Nail Disorders

14.4.1. Nail Plate Disorders
14.4.2. Nail Bed Disorders
14.4.3. Coloration Disorders

14.5. Acne

14.5.1. Pathophysiology and Epidemiology
14.5.2. Types of Acne

14.6. Update on the Management and Treatment of Acne
14.7. Eccrine Gland Disorders
14.8. Apocrine Gland Disorders
14.9. Scarring Alopecia
14.10. Hair Color Disorders
14.11. Ectodermal Dysplasias

Module 15. Pigmentary Pathology, Benign and Malignant Tumor Pathology

15.1. Nevi

15.1.1. Melanocytic Nevi
15.1.2. Congenital Melanocytic Nevi
15.1.3. Becker’s Nevus, Nevus Spilus, Halo Nevus
15.1.4. Spitz Nevus
15.1.5. Atypical Nevus and Familial Dysplastic Nevus-Melanoma Syndrome

15.2. Benign Tumors

15.2.1. Epidermal, Sebaceous, Comedonal Nevi and Syndromes
15.2.2. Benign Adnexal Tumors
15.2.3. Dermal, Subcutaneous Cellular Tissue, Muscular, and Benign Bone Tumors

15.3. Intermediate Malignant and Malignant Tumors

15.3.1. Basal Cell Carcinoma and Squamous Cell Carcinoma
15.3.2. Mastocytosis
15.3.3. Cutaneous Lymphomas
15.3.4. Infantile Fibromatosis
15.3.5. Dermatofibrosarcoma Protuberans

15.4. Dermatoses Combining Hypo- and Hyperpigmentation and Dermatoses with Hyperpigmentation
15.5. Hypopigmented Dermatoses

15.5.1. Pathologies with Congenital/Early Childhood Hypopigmentation
15.5.2. Pathologies with Acquired Hypopigmentation

15.6. Melanoma

Module 16. Infectious Pathology in Pediatric Dermatology 

16.1. Viral Infections I

16.1.1. Herpes Simplex Virus Infection I and II
16.1.2. Varicella Zoster Virus Infection
16.1.3. Non-HSV and VZV Herpesvirus Infection

16.2. Viral Infections II

16.2.1. Parvovirus B19 and Enterovirus Infection
16.2.2. Cytomegalovirus and Epstein-Barr Virus infection
16.2.3. Human Papillomavirus Infection
16.2.4. Poxvirus, Parapoxvirus, and Orthopoxvirus Infection
16.2.5. Viral Exanthem

16.3. Bacterial Infections I

16.3.1. S. Aureus Infections
16.3.2. Streptococcal Infections

16.4. Bacterial Infections II

16.4.1. Infections by Other Gram-Positive Bacteria
16.4.2. Infections by Gram-Negative Bacilli and Cocci
16.4.3. Mycobacterial Infections

16.5. Sexually Transmitted Diseases

16.5.1. Syphilis
16.5.2. Neisseria Gonorrhoeae Infection
16.5.3. Chlamydia Trachomatis Infection
16.5.4. HIV Infection
16.5.5. Notifiable Diseases: What They Are and How to Declare Them?

16.6. Fungal Infections

16.6.1. Superficial Mycoses
16.6.2. Deep Mycoses

16.7. Protozoal and Helminth Infections

16.7.1. Leishmaniasis
16.7.2. Helminth Infections

16.8. Infestations and Stings

16.8.1. Arthropod and Insect Bites
16.8.2. Pediculosis and Scabies

Module 17. Genodermatosis 

17.1. Neurofibromatosis (NF) and Tuberous Sclerosis (TS)

17.1.1. Neurofibromatosis
17.1.2. Tuberous Sclerosis

17.2. Update on the Management and New Perspectives in the Treatment of NF and TS
17.3. Other Rasopathies
17.4. Porphyrias
17.5. Photosensitive Genodermatosis
17.6. Tumor Syndromes
17.7. Other Genodermatoses
17.8. Non-Syndromic Ichthyosis

17.8.1. Ichthyosis Vulgaris
17.8.2. X-Linked Recessive Ichthyosis
17.8.3. Keratinopathic Ichthyoses
17.8.4. Autosomal Recessive Congenital Ichthyosis (ARCI)

17.9. Syndromic Ichthyosis

17.9.1. Sjögren-Larsson Syndrome
17.9.2. Conradi-Hünermann-Happle Disease
17.9.3. Multiple Sulfatase Deficiency
17.9.4. Refsum Disease
17.9.5. Neutral Lipid Deposition with Ichthyosis Disease
17.9.6. CHILD Syndrome
17.9.7. KID Syndrome
17.9.8. Other Syndromes

17.10. Other Cornification Disorders

17.10.1. Erythrokeratoderma
17.10.2. Porokeratosis
17.10.3. Darier and Haley-Haley Disease
17.10.4. Palmoplantar Keratoderma I
17.10.5. Palmoplantar Keratoderma II

17.11. Main Hereditary Diseases; Diagnostic Process and Genetic Counseling
17.12. Principles of Medical Genetics
17.13. Application of the Whole Genome Array Technique in Pediatric Dermatology
17.14. Optimization of Medical Genetics Resources Applied to Pediatric Dermatology

Module 18. Systemic Pathology with Cutaneous Involvement 

18.1. Dermatomyositis 

18.1.1. Diagnosis
18.1.2. Treatment
18.1.3. Advances

18.2. Scleroderma

18.2.1. Diagnosis
18.2.2. Treatment
18.2.3. Advances

18.3. Other Collagenopathies

18.3.1. Anetoderma 
18.3.2. Mixed Connective Tissue Disease 
18.3.3. Sjögren's Syndrome
18.3.4. Relapsing Polychondritis

18.4. Autoinflammatory Diseases

18.4.1. Classification
18.4.2. Diagnosis
18.4.3. Treatment
18.4.4. Advances

18.5. Lupus Erythematosus and Antiphospholipid Syndrome

18.5.1. Diagnosis
18.5.2. Treatment
18.5.3. Advances

Module 19. Skin Pathology Due to External Agents and Physical Damage: Other Pathologies

19.1. Cutaneous Signs of Abuse and Mistreatment

19.1.1. Abuse
19.1.2. Abuse

19.2. Cutaneous Pathology due to External Agents I

19.2.1. Cold
19.2.2. Heat and Pressure
19.2.3. Solar Radiation
19.2.4. Sunburns

19.3. Cutaneous Pathology due to External Agents II

19.3.1. Photodermatoses: Solar Urticaria, Actinic Prurigo, Polymorphous Light Eruption, Juvenile Spring Eruption, Hydroa Vacciniforme
19.3.2. Toxins, Poisons
19.3.3. Self-Induced Dermatoses: Factitious Dermatitis

19.4. Cutaneous Reactions to Drugs

19.4.1. Toxicoderma
19.4.2. DRESS
19.4.3. NET/SSJ
19.4.4. Fixed Drug Erythema
19.4.5. Acute Generalized Exanthematous Pustulosis
19.4.6. Other Cutaneous Reactions to Drugs

19.5. Urticaria

19.5.1. On Contact
19.5.2. Physical
19.5.3. Anaphylaxis
19.5.4. Angioedema
19.5.5. Chronic Urticaria

Module 20. New Developments in Diagnostic Imaging Techniques, Laser Treatment and Pediatric Dermatologic Surgery 

20.1. Use of Ultrasound in Pediatric Dermatology

20.1.1. Use of Ultrasound in Inflammatory Pathology
20.1.2. Basic Principles
20.1.3. Clinical Cases
20.1.4. Role of Ultrasound in Pediatric Dermatology Consultation
20.1.5. Use of Ultrasound in Tumor Pathology
20.1.6. Clinical Cases

20.2. Laser in the Treatment of Pediatric Dermatological Pathology

20.2.1. Types of Lasers Available and Cost-Effectiveness in Pediatric Dermatology Consultation
20.2.2. How to use Lasers on Pediatric Patients
20.2.3. Indications in Pediatric Dermatology

20.3. Surgical Techniques in Pediatric Dermatology 
20.4. Types of Sedation and Anesthesia in Pediatric Surgery

20.4.1. Local Anesthesia
20.4.2. Sedation
20.4.3. General Anesthesia
20.4.4. Controversies in Pediatric Anesthesia

Module 21. Advances in Childhood Blistering Diseases 

21.1. Hereditary Blistering Diseases

21.1.1. Epidermolysis Bullosa Simplex
21.1.2. Junctional Epidermolysis Bullosa
21.1.3. Dystrophic Epidermolysis Bullosa

21.2. Advances in the Management and Treatment of Hereditary AD
21.3. Blistering Autoimmune Diseases I

21.3.1. Bullous Pemphigoid
21.3.2. Pemphigoid
21.3.3. Chronic Childhood Blistering Disease

21.4. Blistering Autoimmune Diseases II

21.4.1. Epidermolysis Bullosa Acquisita
21.4.2. Dermatitis Herpetiformis
21.4.3. Bullous Systemic Lupus Erythematosus

21.5. Management of Immunosuppressant Drugs in Childhood I

21.5.1. Immunosuppressive Drugs
21.5.2. Indications
21.5.3. Management

21.6. Management of Immunosuppressant Drugs in Childhood II

21.6.1. Study of the Patient as a Candidate for Immunosuppressants
21.6.2. Vaccination and Subsequent Management of the Patient Candidate for Immunosuppressants

A unique, key and decisive program to boost your professional development”